The Lancet Respiratory Medicine in conversation with

Ruvim Izĭckson on a joint flu and COVID-19 vaccine

January 31, 2022 The Lancet Respiratory Medicine
The Lancet Respiratory Medicine in conversation with
Ruvim Izĭckson on a joint flu and COVID-19 vaccine
Show Notes

Ruvim Izĭckson discusses the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine together with a third dose of the Moderna COVID-19 vaccine in adults aged 65 years and older.

Read the full article:
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 year

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv